Keyphrases
Monoclonal Antibody
100%
Receptor-binding Domain
100%
Severe Acute Respiratory Syndrome Coronavirus 2 Variants
100%
Variants of Concern
80%
Epitope
40%
Angiotensin-converting Enzyme 2 (ACE2)
40%
Spike Protein
40%
Subnanomolar
40%
High Affinity
20%
Transgenic Mice
20%
Clinical Disease
20%
Mutagenesis Studies
20%
Vaccine Therapy
20%
Therapeutic Efficacy
20%
Transmissibility
20%
Hydrophobic Effect
20%
Rhesus Macaque Model
20%
Cryo-electron Microscopy Structure
20%
Therapeutic Antibody
20%
Viral Burden
20%
Binding Epitope
20%
Potential Clinical Applications
20%
Animal Safety
20%
Half Maximal Inhibitory Concentration
20%
Havoc
20%
Delta Variant
20%
Beta Variant
20%
Contact Interface
20%
Cocktail Therapy
20%
Immunology and Microbiology
Monoclonal Antibody
100%
Receptor Binding
100%
Neutralization
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Epitope
60%
Spike
60%
Angiotensin
40%
Mutagenesis
20%
Transgenic Mouse
20%
Rhesus Monkey
20%
Viral Load
20%
Cryo-Electron Microscopy
20%
IC50
20%
Therapeutic Antibodies
20%
In Vitro
20%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Monoclonal Antibody
100%
SARS Coronavirus
100%
Epitope
60%
Angiotensin Converting Enzyme 2
40%
Mutagenesis
20%
Transgenic Mouse
20%
Combination Therapy
20%
Cryo-Electron Microscopy
20%
Rhesus Monkey
20%
IC50
20%
Delta Variant
20%
Hydrophobic Effect
20%
Diseases
20%
Neuroscience
Monoclonal Antibody
100%
Receptor Binding
100%
SARS Coronavirus
100%
Epitope
60%
Angiotensin Converting Enzyme 2
40%
In Vitro
20%
Cryo-Electron Microscopy
20%
Therapeutic Antibodies
20%
Mutagenesis
20%